Insight Molecular Diagnostics Inc (IMDX)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-04
$2.65-3.28%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-04
QuarterlyIQ Insights · IMDX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||
| Revenues | 1.7 | 4.1 | 1.9 | 1.5 | 1.0 | 2.2 | 1.2 | — | — | — | — |
| Cost of Revenues | 0.9 | 1.8 | 1.1 | 1.0 | 0.9 | 0.7 | 1.9 | — | — | — | — |
| Gross Profit | 0.8 | 2.3 | 0.7 | 0.4 | (0.0) | 1.4 | (0.6) | — | — | — | — |
| Operating Expenses & Income | |||||||||||
| R&D Expenses | 19.1 | 15.9 | 9.8 | 9.3 | 7.3 | 5.0 | 9.8 | 6.8 | 6.5 | 7.2 | 5.7 |
| Operating Income | (50.3) | (51.1) | (61.0) | (25.1) | (18.0) | (53.7) | (29.7) | (22.2) | (15.2) | (18.8) | (11.1) |
| Earnings from Continuing Operations | |||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | 0.0 |
| Other Non-Operating Income / Expenses | 0.9 | 0.9 | 0.4 | 0.3 | (0.6) | 0.9 | (1.5) | (0.2) | (0.6) | (0.5) | (0.0) |
| Asset Writedown | — | — | — | 1.3 | — | — | — | 0.6 | — | 0.0 | 0.0 |
| EBT, Incl. Unusual Items | — | — | (60.7) | (24.9) | (18.6) | (52.9) | (31.2) | — | — | — | — |
| Income Tax Expense | — | — | — | 0.0 | — | (9.3) | (1.3) | — | — | — | — |
| Earnings from Continuing Operations | (49.4) | (50.2) | (60.7) | (24.9) | (18.6) | (43.6) | — | — | — | — | — |
| Net Income | |||||||||||
| Net Income | 0.8 | (50.2) | (60.7) | (0.0) | (72.9) | (64.1) | (29.9) | (22.4) | (15.8) | (19.4) | (11.2) |
| Per Share | |||||||||||
| Basic EPS | 0.02 | (1.65) | (4.66) | (3.75) | (13.25) | (0.72) | — | — | — | — | — |
| Diluted EPS | 0.02 | (1.65) | (4.66) | (3.75) | (13.25) | — | — | — | — | — | — |
| Revenue per Share | 0.05 | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 36.8 | 30.5 | 13.1 | 7.7 | 5.5 | 0.1 | — | — | — | — | — |
| Diluted Weighted Avg Shares | 36.8 | 30.5 | 13.1 | 7.7 | 5.5 | — | — | — | — | — | — |
| Supplemental | |||||||||||
| EBITDA | — | (48.9) | (59.6) | (23.5) | (16.5) | (52.9) | (29.4) | — | — | — | — |
| EBIT | (50.3) | (51.1) | (61.0) | (25.1) | (18.0) | (53.7) | (29.7) | (22.2) | (15.2) | (18.8) | (11.1) |
| Effective Tax Rate | — | — | — | 0.0% | — | 17.5% | 4.0% | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.